Divi's Laboratories (NSE:DIVISLAB) E10: ₹87.10 (As of Mar. 2026)


NSE:DIVISLAB Divi's Laboratories Ltd NSE:DIVISLAB
94 GF Score
Price ₹6,753.50
GF Value ₹6,729.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Divi's Laboratories E10?

Divi's Laboratories NSE:DIVISLAB +0.10% 94 E10 is ₹87.10 as of Mar. 2026. GuruFocus rates NSE:DIVISLAB with a GF Score™ of 94/100 and a GF Value™ of ₹6,729.63 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Divi's Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹28.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹87.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Divi's Laboratories's average E10 Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Divi's Laboratories's current stock price is ₹6753.50. Divi's Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹87.10. Divi's Laboratories's Shiller PE Ratio of today is 77.54.

During the past 13 years, the highest Shiller PE Ratio of Divi's Laboratories was 83.03. The lowest was 66.80. And the median was 73.95.


Divi's Laboratories  (NSE:DIVISLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Divi's Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6753.50/87.10
=77.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Divi's Laboratories was 83.03. The lowest was 66.80. And the median was 73.95.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Divi's Laboratories E10 Related Terms


Divi's Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Divi's Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Divi's Laboratories E10 Chart

Divi's Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 82.08 87.10

Divi's Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.08 83.18 85.15 85.74 87.10

NSE:DIVISLAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Divi's Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's Shiller PE Ratio falls into.


NSE:DIVISLAB
94GF Score
Divi's Laboratories Ltd NSE:DIVISLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Divi's Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Divi's Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=28.31/164.2724*164.2724
=28.310

Current CPI (Mar. 2026) = 164.2724.

Divi's Laboratories Quarterly Data

per share eps CPI Adj_EPS
201103 0.000 70.768 0.000
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 10.080 111.317 14.875
201809 15.210 115.142 21.700
201812 14.670 115.142 20.930
201903 11.000 118.202 15.287
201906 10.260 120.880 13.943
201909 13.440 123.175 17.924
201912 13.530 126.235 17.607
202003 14.620 124.705 19.259
202006 18.540 127.000 23.981
202009 19.570 130.118 24.707
202012 17.730 130.889 22.252
202103 18.910 131.771 23.574
202106 20.990 134.084 25.716
202109 22.840 135.847 27.619
202112 33.990 138.161 40.414
202203 33.700 138.822 39.878
202206 26.440 142.347 30.512
202209 18.600 144.661 21.122
202212 11.560 145.763 13.028
202303 12.090 146.865 13.523
202306 13.410 150.280 14.659
202309 13.110 151.492 14.216
202312 13.500 152.924 14.502
202403 20.250 153.035 21.737
202406 16.200 155.789 17.082
202409 19.200 157.882 19.977
202412 22.200 158.323 23.034
202503 24.930 157.552 25.993
202506 20.490 159.755 21.069
202509 25.970 162.289 26.287
202512 21.980 163.281 22.113
202603 28.310 164.272 28.310

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹87.10 mean?
Divi's Laboratories (NSE:DIVISLAB) has a E10 of ₹87.10 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Divi's Laboratories and its competitors.
Is Divi's Laboratories' E10 too high?
Divi's Laboratories' current E10 is ₹87.10. Overall, Divi's Laboratories has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Divi's Laboratories' E10 compare to ZTS?
Divi's Laboratories' E10 of ₹87.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Divi's Laboratories and its competitors. Divi's Laboratories's current E10 is ₹87.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Divi's Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Divi's Laboratories (NSE:DIVISLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹6,729.63, compared to a current price of ₹6,753.50 — trading 0.4% above its estimated fair value. The current E10 is ₹87.10. Divi's Laboratories' overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Divi's Laboratories (NSE:DIVISLAB), the current E10 is ₹87.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Divi's Laboratories (NSE:DIVISLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Divi's Laboratories stock appears to be overvalued. The current stock price of ₹6,753.50 is trading 0.4% above its estimated GF Value™ of ₹6,729.63. GuruFocus considers Divi's Laboratories to be Fairly Valued.

Key valuation signals for NSE:DIVISLAB:

  • E10: ₹87.10
  • GF Value™: ₹6,729.63 vs. price of ₹6,753.50 (0.4% above fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the NSE:DIVISLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Divi's Laboratories Business Description

Other Exchanges 532488:India
Address Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032
Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients, with a predominance in exports. It also, through its custom synthesis, supports pharma companies for their patented products business from gram-scale requirements for clinical trials to launch, as well as late-life cycle management. Geographically, the company derives maximum revenue from Europe, and the rest from America, India, Asia (excluding India), and the Rest of the world.
94GF Score

Get the complete analysis for NSE:DIVISLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6,753.50
Price
₹6,729.63
GF Value